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Abstract 
Cartilage and osteochondral defects pose a significant challenge in orthopaedics. 
Tissue engineering has shown promise as a potential method for the treatment of such 
defects, however, a long lasting repair strategy has yet to be realised. This study 
focuses on the development of a layered construct for osteochondral repair, fabricated 
through a novel ‘iterative layering’ freeze-drying technique. The process involved 
repeated steps of layer addition followed by freeze-drying, enabling control over 
material composition, pore size and substrate stiffness in each region of the construct, 
while also achieving a seamlessly integrated layer structure. The novel construct 
developed mimics the inherent gradient structure of healthy osteochondral tissue; 
containing a bone layer composed of type I collagen and hydroxyapatite, an 
intermediate layer composed of type I collagen, type II collagen and hydroxyapatite, 
and a cartilaginous region composed of type I collagen, type II collagen and 
hyaluronic acid. The material properties were designed to provide the biological cues 
required to encourage infiltration of host cells from the bone marrow while the 
biomechanical properties were designed to provide an environment optimised to 
promote differentiation of these cells towards the required lineage in each region. This 
novel osteochondral graft was shown to have a seamlessly integrated layer structure, 
high levels of porosity (>97%), a homogenous pore structure and a high degree of 
pore interconnectivity. Moreover, homogenous cellular distribution throughout the 
entire construct was evident following in vitro culture demonstrating the potential of 
this multi-layered scaffold as an advanced strategy for osteochondral defect repair. 
 
 
Keywords 
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1. Introduction 
Osteochondral defects, involving the smooth cartilage lining of the articulating 
surface and the underlying subchondral bone, frequently occur due to disease or as a 
result of traumatic injury to the joint [1]. Due to the body’s extremely limited capacity 
to repair such defects, the prognosis is chronic degradation and surgical intervention 
is frequently required [2]. The treatment options dependent on factors such as age, 
lesion diameter and depth, and location within the joint [3,4]. Autologous 
osteochondral grafting is currently recognised as the clinical gold-standard for the 
treatment of osteochondral defects. However, this technique possesses many inherent 
limitations including donor site morbidity, limited quantity of suitable host tissue as 
well as the difficulty in correctly matching the topography of the graft with the 
healthy tissue surrounding the defect site [5]. Issues including incomplete integration 
between the host tissue and graft tissue [6] and the degradation of the graft tissue are 
often observed [7]. Tissue Engineering (TE) strategies may provide significant 
advantages compared to these more traditional clinical treatment methods. Two 
approaches are typically used, (i) cell-free scaffolds, which relies on the principal that 
the patient’s own cells infiltrate into the scaffold and subsequently synthesise repair 
tissue; and (ii) cell-seeded scaffolds whereby cells are harvested from the patient and 
cultured in vitro on a scaffold prior to implantation. In both situations, the properties 
of the scaffold, including porosity, pore size [8,9] and substrate stiffness [10,11] are 
known to be key determinants which influence cellular attachment, infiltration and 
lineage specification of mesenchymal stem cells (MSCs).  
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While cell-seeded approaches tend to place less focus on the scaffolds and rely mainly 
on the delivered cells to engineer the repair tissue, cell-free scaffolds used in 
osteochondral TE place particular emphasis on the composition and structure of the 
scaffold. This is done in an effort to provide an environment that can support the 
existing host cell population thereby circumventing the costly and cumbersome 
requirement of in vitro pre-culture prior to implantation. Numerous scaffolds utilised 
in this area consist of synthetic materials, such as poly(e-caprolactone) (PCL) [12], 
poly(glycolic acid) (PGA) [13] and poly(lactide-co-glycolide) (PLGA) [14,15]. 
However, slow degradation rates, harmful degradation by-products, poor cell 
attachment, inability to direct cellular differentiation, and reduced immunogenicity 
have led to limited long-term success following in vivo application [13]. Natural 
materials, including collagen [16,17] fibrin [18], hyaluronan [19], alginate [20] and 
agarose [21-23], have been widely investigated for use in osteochondral tissue repair. 
In particular, collagen offers advantages over synthetic materials including the 
presence of biochemical cues that support cell attachment, proliferation, migration 
and differentiation. Collagen has been co-polymerised with other naturally derived 
materials in order to improve their biofunctionality. Moreover, they degrade without 
the release of harmful by-products.  
 
One of the major challenges in the development of biomaterials for osteochondral 
application is to adequately mimic the gradient structure of natural osteochondral 
tissue with distinct but seamlessly integrated layers appropriately designed to repair 
bone, calcified cartilage and articular cartilage. The first generation of constructs 
involved fabrication of two separate scaffolds; one designed to repair the cartilage 
tissue and the other designed to repair bone tissue. These two scaffolds were 
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subsequently fused together using sutures [25,25] or biological sealants or glues 
[19,26,27]. Success of such materials has been limited due to poor cellular infiltration 
through the layers of the structure. In addition, such bilayered scaffolds were not 
designed to regenerate the calcified cartilage region which forms the interface 
between the bone and cartilage regions of osteochondral tissue and plays an important 
functional role in the prevention of vascular invasion from bone into cartilage. The 
absence of a calcified cartilage region results in an unstable interface which can result 
in bony ingrowth into cartilage region of the defect space [28]. 
 
The approach used in the current study builds on our research group’s expertise in the 
development of collagen-based biomaterials for tissue regeneration. This study set out 
to develop a collagen-based multi-layered scaffold with distinct but seamlessly 
integrated layers that mimic the structure and composition of osteochondral tissue 
while also showing potential for use clinically as a cell-free scaffold that would allow 
the attachment, proliferation and infiltration of the host’s own cells recruited from the 
bone marrow while also providing an optimised intermediate layer, seamlessly 
integrated and designed to mimic the calcified cartilaginous interface once implanted 
in vivo. We hypothesised that an ideal scaffold for osteochondral repair could be 
produced by combining a base layer consisting of a collagen hydroxyapatite scaffold 
exhibiting osteoinductive properties and potential for bone repair [29] with a 
collagen-HA-glycosaminoglycan intermediate calcified cartilage layer, and finally a 
pro-chondrogenic collagen-hyaluronic acid based cartilaginous layer [30].  
 
The study aimed to investigate the structural and micro-architectural properties of the 
final construct and in addition to assess the biological performance of the scaffold in 
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vitro, determining the biocompatibility of the scaffold, the attachment and 
proliferation of cells on the scaffold, and the ability of cells to infiltrate through the 
porous architecture and distribute evenly throughout construct.  
 
2. Materials and Methods 
In order to fabricate the multi-layered osteochondral scaffold, a series of preliminary 
experiments were carried out. These include investigations into different methods of 
hydration and lyophilisation of the individual scaffold layers prior to addition of the 
overlying layers, distinct freezing regimes, to enable complete freezing of the 
collagen-based suspensions, as well as various drying programmes to ensure complete 
drying of the scaffold. The optimised method, termed the ‘Iterative Layering 
Fabrication Method, illustrated in Figure 1, is described here. 
 
2.1. Scaffold Fabrication 
2.1.1. Preparation of collagen-based suspensions 
Bone layer suspension: The bone mimicking region of the scaffold was based on a 
novel bone repair scaffold, HydroxyColl [31], which was previously developed within 
our group and is currently being commercialised by a campus spin out company under 
the trade name SurgaColl Technologies. The HydroxyColl scaffold is composed of 
type I collagen and hydroxyapatite and was prepared as described previously [29]. 
Briefly, microfibrillar bovine tendon type I collagen (Col1) (Collagen Matrix Inc., NJ, 
USA) was blended with 0.5 M acetic acid solution (pH 2.8) for 90 minutes in a cooled 
reaction vessel using an IKA Ultra Turrax T18 overhead blender (IKA Works Inc., 
Wilington, NC) at a speed of 15,000 rpm. Hydroxyapatite (HA) powder (Captal ‘R’ 
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Reactor Powder, Plasma Biotal, UK) was suspended in 0.5 M acetic acid solution and 
added in aliquots to the collagen suspension every hour during blending to give a 
collagen-hydroxyapatite (CHA) suspension with a final collagen concentration of 
0.5% (w/v) and HA concentration of 1% (w/v).  
 
Intermediate layer suspension: The intermediate layer suspension is composed of type 
I collagen (Col1), type II collagen (Col2) (Porcine type 2 collagen, Biom’up, Lyon, 
France) and HA. Col1 (0.5% (w/v)) and Col2 (0.5% (w/v)) were blended in 0.5 M 
acetic acid. The HA was added similarly to the bone layer suspension described 
above, to give a HA concentration of 0.2 % (w/v).   
 
Cartilage layer suspension: The cartilage mimicking layer contains Col1, Col2 and 
hyaluronic acid sodium salt derived from streptococcus equi (HyA) (Sigma-Aldrich, 
Arklow, Ireland). The suspension was produced by blending Col1 (0.125% (w/v) and 
Col2 (0.375% (w/v) in 0.5 M acetic acid for 90 minutes. HyA was dissolved in 0.5 M 
acetic acid, using a previously developed method [30], and subsequently added into 
the Col1:Col2 suspension at a concentration of 0.05% (w/v). Following blending, 
suspensions were degassed under a vacuum of 10 mbar for 10 minutes.  
 
2.1.2. Iterative Layering Fabrication Process 
The bone layer scaffold was fabricated using a previously described optimised freeze-
drying method [29]. Briefly, 15.6 ml of the bone layer suspension was pipetted into a 
stainless-steel tray (internal dimensions - 60mm x 60mm) and subsequently placed 
into a freeze-dryer (Virtis Genesis 25EL, Biopharma, Winchester, UK). This was then 
freeze-dried at a constant cooling rate of 1 °C/min to a final freezing temperature of -
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40°C [9,32]. Following freeze-drying, the scaffold was crosslinked using a 1-ethyl-3-
3-dimethyl aminopropyl carbodiimide (EDAC)/ N-Hydroxysuccinimide (NHS) 
(Sigma-Aldrich, Arklow, Ireland) using a concentration of 6 mM EDAC per gram of 
collagen and a 5:2 molar ratio of EDAC:NHS [33]. Crosslinking was carried out for 2 
hours at room temperature, after which scaffolds were rinsed several times to 
eliminate water soluble urea, which is a by-product of the reaction. This crosslinking 
step improves the bulk stiffness of the base layer in order to provide it with sufficient 
structure to support the addition of the overlying intermediate layer.  
 
The crosslinked bone layer scaffold was subsequently hydrated using 0.025 M acetic 
acid solution within the stainless steel tray. The 0.025 M acetic acid acts as a support 
to the bone layer scaffold during addition of the next layer and also enables thermal 
conduction through the pre-formed scaffold. The second layer was then added by 
pipetting 7.8ml of the intermediate layer suspension on top of the hydrated bone layer 
scaffold and freeze-drying using a similar protocol as before at a constant freezing 
rate of 1°C/min to a final freezing temperature of – 40°C. This resulted in a highly 
porous 2-layered scaffold composed of the bone layer and intermediate layer. 
 
The rehydration process described above was repeated for the 2-layered scaffold prior 
to addition of 15.6ml of the cartilage layer suspension. This was then freeze-dried 
using a freeze-drying cycle similar to that already described; a constant freezing rate 
of 1°C/min and final freezing temperature of – 40°C, but with the inclusion of 
prolonged freezing and drying steps to ensure optimal freeze-drying of the construct. 
This was carried out based on preliminary work which indicated that poor micro-
structural properties and incomplete drying resulted when using the standard freeze-
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drying protocol. A thermocouple probe was placed in the each collagen suspension 
during the freeze-drying cycle in order to monitor the thermal profile. The fabrication 
process is summarised in Figure 1.  
 
Following freeze-drying, the porous 3-layered scaffolds underwent dehydrothermal 
(DHT) treatment in a vacuum oven (Vacucell 22; MMM, Germany) at a temperature 
of 105°C under a vacuum of 0.05 bar for 24 hours. This was carried out to create 
crosslinks through a condensation reaction which results in amide bonds. In addition, 
the process also sterilised the scaffolds prior to in vitro assessment. Cylindrical 
scaffold samples of 9.5 mm diameter were cut from the scaffold sheet using a metal 
punch for further analysis. 
 
2.2. Scaffold Characterisation 
Analysis was carried out on the final 3-layered scaffold and also on the individual 
component layers of the scaffold. In addition, a collagen-only single layer scaffold 
fabricated using the standard -40ºC freeze-drying recipe was used as a control in this 
study [34]. This collagen-only control was selected in order to allow the effect of 
adding components such as Col2, HyA and HA to be determined. All scaffolds were 
sterilised using a dehydrothermal (DHT) treatment method in a vacuum oven 
(Vacucell 22; MMM, Germany) at a temperature of 105°C under a vacuum of 0.05 
bar for 24 hours prior to testing. 
 
2.2.1. SEM Analysis 
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The scaffold micro-architecture was analysed using scanning electron microscopy 
(SEM) (JEOL 840 73, Joel, Japan). Samples were mounted on sample holders and 
placed in a SEM chamber without prior addition of a sputter coating. Scan settings of 
15KeV and 3x10-10 A were used.  
  
2.2.2. Porosity  
The porosity of each of the component layers of the 3-layered scaffold was 
determined using a method based on the relative density of the freeze-dried material 
[29]. Scaffold volume was determined by measuring the sample dimensions using 
vernier callipers, and the mass using a mass balance. The relative density of the 
scaffolds was calculated and the percentage porosity was calculated using equation 1. 
     
Porosity (%) = (1 – ρ scaffold / ρ solid) x 100       [1]
  
2.2.3. Scaffold Pore Size 
Scaffold pore structure and pore size analysis was carried out using a technique 
described previously [9]. Scaffold samples were embedded in JB-4 
glycolmethacrylate (Polysciences Europe, Eppelheim, Germany) and then sectioned 
using a microtome (Leica RM 2255, Leica, Germany) to provide sections of 10µm in 
thickness. These were mounted on slides and stained using toluidine blue (Sigma-
Aldrich, Arklow, Ireland). Digital images were captured at a magnification of 10x 
using a microscope (Eclipse 90i, Nikon, Japan) and a digital camera (DS Ri1, Nikon, 
Japan). Pore size analysis was carried out using a MATLAB (MathWorks Inc, MA, 
USA) based Pore Topology Analyser programme previously described [34]. The 
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programme converts the digital images into binary form and calculates the average 
pore size based on the best fit elliptical lengths generated by the software.  
 
2.2.4. Mechanical Testing 
The mechanical properties were assessed through unconfined compression testing 
using a Zwick Z050 mechanical testing machine and integrated testing software 
testXpert (Zwick/Roell GmbH, Ulm, Germany). Scaffold samples were prehydrated 
in PBS for 1 hour prior to testing and immersed in PBS throughout the tests. Testing 
was carried out using a 5 N load cell at a strain rate of 10% per minute, up to a 
maximum of 10% strain. The compressive modulus was defined as the slope of a 
linear fit to the stress-strain curve over 2-5% strain. [34,35]. 
 
2.2.5. Interfacial Adhesion Strength 
Interfacial adhesion strength between the layers of the construct was determined using 
a custom designed interfacial strength test rig fitted to a Zwick Z050 Mechanical 
Testing Machine (Zwick/Roell GmbH, Ulm, Germany). The rig design allows the 
secure fixation of the scaffold during testing while ensuring correct alignment of the 
scaffold between the machine’s load cell and base platen. Scaffold samples were 
adhered to aluminium test stubs using a high viscosity adhesive (Araldite, Radionics, 
Ireland) and inserted into the rig for testing. The high viscosity of the adhesive used 
ensured minimal integration into the scaffold. This was confirmed by applying the 
adhesive to the scaffold and inspecting the depth of penetration following sectioning. 
Samples were hydrated in PBS for 1 hour prior to testing to failure using a 5 N load 
cell under a tensile load applied at a strain rate of 10% per minute. Failure was 
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expected to occur either at the ultimate tensile strength of one of the component layers 
of the scaffold or as a result of delamination at the layer interfaces. 
 
2.3. In vitro Analysis 
In vitro analysis was carried out in order to assess scaffold biocompatibility, cellular 
attachment and the ability of cells to infiltrate through the layered structure of the 
scaffold. Scaffold discs, 12.7 mm (½") in diameter and 4 mm in height, were seeded 
with MC3T3-E1 mouse pre-osteoblast cells (ATCC-LGC, Teddington, Middlesex, 
UK) at a density of 1 x 106 cells per scaffold. Cell-seeded scaffolds were cultured in 
alpha-minimum essential medium (α-MEM) (Biosera, Ringmer, UK) supplemented 
with 2% penicillin/streptomycin (Sigma-Aldrich, Arklow, Ireland), 1% L-glutamine 
(Sigma-Aldrich, Arklow, Ireland) and 10% foetal bovine serum (Biosera, Ringmer, 
UK) at 37°C and 5% CO2 and evaluated at 7 and 14 days post seeding. In order to 
determine scaffold viability, cell number was determined by DNA quantification 
using a Hoechst DNA assay (Sigma-Aldrich) (n=4). Scaffolds were homogenised 
with 1ml Qiazol (Qiagen, Crawley, UK) using a hand-held homogeniser (Finemech, 
Portola Valley, CA, USA). Cell number was quantified using a Fluorescent Hoechst 
dye 33 258 assay as previously described [8]. Measurements were taken from a 
fluorometric plate reader (Wallac 1420 Victor2 D, Perkin Elmer, MA, USA) at an 
emission of 460 nm and excitation of 355 nm, 1.0 s. The measurements were read 
against a standard curve to obtain the relative cell numbers per scaffold in terms of the 
DNA content. 
 
Histological analysis was carried out in order to evaluate how effectively cells 
infiltrated through the layered constructs. Constructs were fixed in 10% formalin for 
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2h and then processed in an automatic tissue processor (ASP300, Leica, Wetzlar, 
Germany). Constructs were then embedded in paraffin wax and sectioned at a 
thickness of 10 µm using a rotary microtome (RM2255, Leica microtome, Leica). 
Sections were stained using haematoxylin and eosin (H&E) staining and digital 
images captured in order to evaluate cell infiltration through the scaffold. 
  
2.4. Statistical analysis 
Data is presented as mean standard deviation. Differences between two treatments 
were assessed using the student’s paired t-test and between 3 or more were assessed 
using one-way ANOVA. Statistical significance was taken at p < 0.05. 
 
3. Results 
3.1. Analysis of Scaffold Architecture 
The homogenous pore structure produced by the freeze-drying process was 
demonstrated using Scanning Electron Microscopy (SEM) analysis of the 3-layered 
scaffold as shown in Figure 2. A high degree of pore interconnectivity throughout the 
construct can be observed. Structural continuity at the interfaces was evident, with the 
individual layers being seamlessly integrated. This seamless integration of the 
scaffold layers is vital in order to promote cell infiltration and the regeneration of 
tissue in the different layers of the scaffold. 
 
Scaffold porosity was found to be > 98.8 % for each of the component layers of the 3 
layered scaffold. A reduction in porosity was seen in scaffolds containing HA, 
however, this reduction (from 99.5% for collagen-only control to 98.8% for bone 
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layer scaffold) was negligible. Layered scaffolds fabricated using the ‘iterative 
layering’ technique maintained the highly porous structure observed for the 
constituent layers when fabricated independently. Investigation of the scaffold pore 
architecture demonstrated the homogenous pore structure present within the scaffold 
(Figure 3a). Measurement of pore size revealed an average pore diameter of 126 µm 
in the cartilage layer, 112 µm in the intermediate layer and 136 µm in the bone layer, 
as shown in Figure 3b. There was no significant difference in the pore size of the bone 
and cartilage regions compared to the collagen only control scaffold. The mean pore 
size in the intermediate layer was found to be smaller than that of the bone and 
cartilage layers (p<0.05, n=4).  
 
3.2. Assessment of Scaffold Mechanical Properties 
The compressive moduli of the constituent layers of the scaffold and of the combined 
3-layer scaffold are compared in Figure 4. The bone layer was found to have the 
highest compressive modulus of approximately 0.95 kPa, significantly higher than the 
other two groups (p<0.05). This is due to the presence of the HA mineral phase in this 
layer. The compressive moduli of the collagen control, the intermediate layer and the 
cartilage layer were found to be approximately 0.4 kPa, 0.35 kPa and 0.3 kPa 
respectively. The compressive modulus of the 3-layered scaffold was found to be 0.51 
kPa. No statistically significant difference (p > 0.05) was found between these groups. 
 
The interfacial adhesion strength for the 2-layered (bone and intermediate layers) and 
3-layered (bone, intermediate and cartilage layers) scaffolds fabricated using the 
‘iterative layering technique’ are shown in Figure 5. Delamination of the different 
layers was not observed during testing. Failure occurred within the intermediate layer 
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in the 2-layered scaffold and within the cartilage layer in the 3-layer scaffold showing 
that the interfacial strength was greater than the tensile strength of the individual 
layers themselves. The tensile properties were lower for the 3-layered scaffold than 
the 2-layer scaffold due to the presence of type II collagen in the cartilage layer of the 
3-layer scaffold. Fibre pullout was observed on the fracture surface following testing 
indicating integration between the scaffold layers. 
 
3.3. In vitro Assessment 
Biocompatibility was assessed by quantifying cell number within the 3-layered 
scaffolds and a collagen only control scaffold. No significant difference in cell 
number was found between the two groups at day 7 post seeding (Fig. 6a). There was 
approximately 50% increase in cell number from day 0 to day 7 and a further 50% 
increase by day 14 for both the collagen control and the 3-layer scaffolds. The 
homogenous distribution of cells within the porous structure of the 3-layered scaffold 
was observed following analysis of H&E stained histological sections at 14 days post 
seeding (Fig. 6b). No encapsulation effect was observed from this analysis. Cellular 
infiltration through all 3 layers of the construct was evident, thus confirming the 
seamless integration at the interfaces of the individual layers. 
 
4. Discussion 
Due to the complex zonal organisation of osteochondral tissue, development of a 
single implantable biomaterial with a gradient structure is of great interest in the field 
of osteochondral tissue engineering [36,37]. This study built on the existing collagen-
based scaffold expertise within our research group to develop a novel multi-layered 
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material for osteochondral repair. The resultant scaffold contains three distinct regions 
appropriately designed for the repair of the chondral, calcified cartilage and 
subchondral bone layers present within healthy osteochondral tissue. Through the 
development of the novel “iterative layering” manufacturing process, the layered 
construct described here can be produced without many of the limitations of existing 
technologies for osteochondral repair, while retaining the core ability to completely 
tailor each region to provide the optimal cues to enable regeneration of the local tissue 
within the defect. Collagen forms the base material for each of the layers of this multi-
layer construct, thus offering the advantage of the presence of natural binding sites 
and the ability to degrade without release of harmful degradation products. By 
combining these biocompatible characteristics, optimised pore structure and 
mechanical environment, with individually tailored composition within each 
respective layer, this novel multilayered scaffold has the potential to offer a cell-free 
“off-the-shelf” approach to osteochondral defect healing. A patent on the technique 
described to fabricate these scaffolds has been filed [38] and the scaffold itself is 
currently being commercialised through a spin out campus company, SurgaColl 
Technologies under the trade name, ChondroColl. As well as showing potential in the 
fabrication of a construct for use in osteochondral repair, the methodology described 
could also be applied for the fabrication of scaffolds for other applications involving 
the repair and regeneration of multi-layered biological tissues. 
 
The material composition of each layer of the scaffold was designed taking into 
account the native extracellular matrix of osteochondral tissue. The superficial layer 
of articular cartilage, which is composed of a rich glycosaminoglycan content and 
type II collagen, the cartilage layer of the scaffold was fabricated from type I 
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collagen, type II collagen and hyaluronic acid. Type II collagen and hyaluronic acid 
have previously shown the potential to induce and maintain MSC chondrogenesis 
within the literature and previous investigations carried out by our group [30,39,].  
Preliminary work in our laboratory demonstrated that scaffolds fabricated from type II 
collagen and hyaluronic acid had poor mechanical properties with subsequent 
difficulty in handling. However, the incorporation of collagen type I significantly 
increased the mechanical properties of the cartilage layer. Type I collagen scaffolds 
have been previously shown in our laboratory to support the chondrogenic 
differentiation of rat bone marrow MSC cells [40]. The calcified cartilage or tidemark 
region of native osteochondral tissue is hypothesised to prevent ingrowth of bone into 
the chondral region in the defect space; a problem frequently observed following 
implantation of earlier 2-layer osteochondral repair materials [28]. The intermediate 
layer of the 3-layer scaffold developed here replicates the composition of the calcified 
cartilage region, containing type I collagen, type II collagen and hydroxyapatite.   
 
Similar to the two overlying layers, the bone layer of the tri-phasic scaffold was 
designed to mimic the native composition of subchondral bone extracellular matrix: 
type I collagen and hydroxyapatite. This layer was found to possess an interconnected 
pore architecture (Fig. 3b), significantly higher compressive modulus than the 
cartilage and intermediate layers (Fig. 4) as well as homogeneous cellular distribution 
following 14 days of culture in vitro (Fig. 6b). Due to the higher compressive 
modulus of subchondral bone compared to articular cartilage, we designed this multi-
layered scaffold with a view to having an increasing gradient of stiffness from the 
cartilage layer to the bone layer. The addition of hydroxyapatite (1% w/v) to collagen 
led to a significant increase in the bulk compressive modulus of the bone layer. A 
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number of studies have shown that the stiffness of substrates can mediate the lineage 
that undifferentiated cells follow [10,41]. Indeed, studies within our laboratory have 
shown that collagen-based scaffolds with stiffer substrates can support initiation of 
MSC osteogenic differentiation in the absence of growth factors [11]. In this context, 
having the bottom bone layer with the highest compressive modulus may encourage 
the osteogenic differentiation of progenitor cells. Moreover, the presence of 
hydroxyapatite particles within this layer, which have been shown to be osteo-
inductive both in vitro and in vivo [29], will also enhance the osteogenic 
differentiation, thus, enhancing its role in the zonal organisation of regenerated 
osteochondral tissue. 
 
 
The micro-structural and mechanical properties of a tissue engineered construct have 
a significant impact on cellular differentiation. The pore size in freeze-dried materials 
is dependent on the freeze-drying parameters used in the fabrication process. To 
achieve a homogenous pore structure, conduction of thermal energy between the 
material being freeze-dried and the freeze-dryer shelf is essential [32]. When freeze-
drying a layered material there is no direct contact between the overlying layer and 
the base of the tray. To overcome this limitation, the rehydration of the bone layer 
was found to facilitate the transfer of thermal energy through the bone layer and to 
enable the desired ice crystal formation during freezing. This enabled control of the 
pore size within each region of the scaffold. Indeed, optimisation of the pore structure 
is crucial since it has been shown that scaffold mean pore size has a considerable 
effect on the response of seeded cells. In particular, Murphy et al. [8] showed that 
both cellular attachment and infiltration are significantly affected by scaffold mean 
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pore size. In addition, research within our laboratory has also shown that scaffold 
mean pore size has a deterministic role in cell differentiation and matrix deposition. 
 
Seamless integration between the layers is essential in order to support our paradigm 
which proposes to utilise and encourage the infiltration of the host’s own cells from 
the bone marrow through all regions of the scaffold. We propose that once sufficient 
infiltration is achieved, the local availability of pro-osteogenic/chondrogenic moieties 
provided by the scaffold (substrate stiffness, architecture, composition) would support 
the generation of layer-specific extracellular matrix, providing an ideal environment 
to encourage early-stage de novo tissue development. SEM investigation (Fig. 2) 
enabled the interfacial regions to be visualised, with layer interfaces between the 
individual layers difficult to distinguish thus confirming the achievement of seamless 
integration between each individual layer through use of this ‘iterative layering’ 
process. To investigate the stability of the integrated layers, interfacial strength at the 
interfaces between each layer was assessed. Poor interfacial strength leads to 
delamination of the layers, a problem widely reported in the fabrication of layered 
scaffold materials for tissue engineering [15,26,27]. Using a custom layer adhesion 
strength measurement technique, the interfacial layer strength was tested to failure, 
with delamination of the layers being found to occur within the confines of the 
mechanically weakest layer (top cartilage layer) rather than at the interface. This 
supports the earlier assessment of seamless integration of the layers, evident by the 
interfaces superior strength compared to the individual layers themselves. Subsequent 
examination of the fracture surfaces following testing exhibited fibre pull out, 
indicating that a bridging of the fibre structure occurs across the interfaces as a result 
of the novel manufacturing process. This process thus provides an ideal composite 
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structure which maximises layer bonding strength without the need for glues or 
sutures.  
 
Substrate stiffness also plays a role in the direction of MSC differentiation; with 
stiffer scaffolds showing differentiation of cells towards an osteogenic lineage and 
less stiff matrices directing MSCs towards a chondrogenic lineage [11]. The iterative 
layering process allows the tailoring of stiffness in each region of the multi-layer 
scaffold (Fig. 4). Having previously optimised the substrate stiffness for osteo- and 
chondro-genesis within these collagen-based constructs, the retention of a seamless 
pore structure throughout the material but coupled with the customisable substrate 
stiffness, via compositional changes or subsequent cross-linking methodologies 
provides a significant amount of flexibility to maximise the potential of this novel 
scaffold for use in osteochondral defect repair. 
 
The ability of cells to attach to and proliferate on the multi-layer scaffold as evidenced 
during in vitro assessment demonstrates the biocompatibility of the scaffold. Little 
difference in cell number was observed between the multi-layer construct and the 
control collagen scaffold indicating that the osteogenic and chondrogenic components 
added during fabrication do not affect the biocompatibility of the scaffold. A highly 
porous material with an interconnected pore structure is essential in order for cells to 
infiltrate through a material, attach to it and begin the deposition of matrix. The 
layered scaffold produced using the iterative layering technique described here has a 
porosity of >97%. This is marginally lower than the porosity of each of the 
constituent layers when fabricated as separate scaffolds, demonstrating that the 
process of layering and freeze-drying has minimal detrimental effect on the porosity 
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of the material. Homogenous cellular distribution throughout the entire construct was 
demonstrated in vitro (Fig. 6b), indicating that the seamless layer integration allows 
cellular infiltration through the construct and confirms that the scaffold has the 
potential to allow host cells to distribute evenly throughout the scaffold’s gradient 
structure following implantation in vivo. The in vitro investigation described here 
indicates the biocompatibility of the scaffold and ability of cells to infiltrate the 
porous structure of the scaffold. The in vivo environment is more complicated, with a 
range of cell types from the blood and bone marrow infiltrating the scaffold following 
implantation. The scaffold is expected to initially provide a site for blood clot 
formation, and following the natural inflammatory response and influx of cells, to 
provide a template that guides the generation of repair tissue. In order to more fully 
understand this process and the regenerative potential of the scaffold, in vivo 
investigation is required. This is the focus of ongoing studies in our laboratory. Taken 
together, these results show the potential of this multi-layered scaffold as an advanced 
strategy for osteochondral defect repair. 
 
5. Conclusions 
In summary, this study has developed a novel, seamlessly integrated tissue 
engineering scaffold for osteochondral repair. The resultant scaffold mimics the 
inherent gradient structure of healthy osteochondral tissue; containing a bone layer, an 
intermediate layer and a cartilaginous layer. The iterative layering technique 
described here has shown advantages over previously reported layered scaffold 
fabrication techniques in terms of the potential for optimisation of the composition, 
pore size, porosity and mechanical properties of each individual layer of the multi-
layered scaffold. As well as showing potential in the fabrication of a construct for use 
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in osteochondral repair, the methodology described can also be applied for the 
fabrication of scaffolds for other applications involving the repair and regeneration of 
multi-layered biological tissues. This novel scaffold provides an optimised 
environment for cell attachment and proliferation due to a seamlessly integrated layer 
structure, high levels of porosity, a homogenous pore structure and a high degree of 
pore interconnectivity, all of which are essential in order to allow cellular infiltration, 
diffusion of nutrients, removal of waste and to promote regeneration of seamless 
anatomical repair tissue. These results suggest that this novel material has 
considerable promise as a scaffold for osteochondral repair. 
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Figures: 
 
 
Fig. 1. Iterative Layering Fabrication Process Diagram. The ‘Iterative Layering 
Process’ is a 3-step process which allows the material composition and scaffold 
micro-architecture in each region of the scaffold to be specifically tailored while 
producing a resultant scaffold with a seamlessly integrated layer structure.  
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Fig. 2. Representative SEM micrographs of the 3-layer scaffold showing the highly 
porous structure, high degree of pore interconnectivity and seamless integration of the 
component layers.  
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Fig. 3a. Comparison of the pore diameters of each of the component layers of the 3-
layer scaffold produced in isolation (*p>0.05, n=4). The average pore diameters were 
found to vary from 112 µm (intermediate layer scaffold) 136 µm (bottom layer 
scaffold).  
 
 
Fig. 3b. Representative micrographs of the pore structure of each of the component 
layers of the 3-layer scaffold. The micrographs show the homogeneous pore 
architecture in each region of the scaffold.  
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Fig. 4. Effect of the layering process on mechanical properties of scaffolds following 
DHT treatment at 105 °C for 24 hours (*p>0.05, n=6).  The presence of HA in the 
bone layer led to an increase in the compressive modulus. The compressive modulus 
of the 3-layer scaffold was found to be 0.51 ± 0.03 kPa. No significant difference was 
found between the collagen control scaffold, the intermediate layer, the cartilage layer 
or the 3-layer scaffold indicating that the ‘iterative layering’ process does not 
negatively affect scaffold mechanical properties. 
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Fig. 5. Layer adhesion strength test results for the 2-layer (bone and intermediate 
layers) and 3-layer (bone, intermediate and cartilage layers) scaffolds fabricated using 
the ‘iterative layering technique’ (*p>0.05, n=8). In all cases, delamination was not 
seen at the interfaces. Instead failure occurred within the intermediate layer in the 2-
layer scaffold and within the cartilage layer in the 3-layer scaffold showing that the 
interfacial strength was greater than the tensile strength of the materials used. The 
tensile properties were lower for the 3-layered scaffold than the 2-layer scaffold due 
to the presence of type II collagen in the cartilage layer of the 3-layer scaffold.  
 
 
Fig. 6a. Cell numbers for 3-layer scaffolds compared to collagen scaffolds at 7 and 14 
days (*p>0.05, n=5). Cell numbers were seen to increase by approximately 50% from 
day 7 to day 14 for both the collagen and the 3-layer scaffolds. The ability of cells to 
proliferate within the 3-layer scaffold indicates the biocompatible nature of the 
scaffold.  
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Fig.6b. Histologically prepared, haematoxylin and eosin (H&E) stained transverse 
sections of the 3-layered scaffold following 14 days in vitro culture with MC3T3-E1 
mouse pre-osteoblast cells. Infiltration of cells was seen throughout the full scaffold 
structure at this time point. Haemotoxylin stained nuclei are indicated by the arrows.  
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